Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis

Abate, Semagn Mekonnen; Checkol, Yigrem Ali; Mantefardo, Bahiru

doi:10.1016/j.amsu.2021.102204

Cited by 48 publications

(68 citation statements)

References 65 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This estimation is upper than large cohort study that reported in-hospital death due to COVID-19 in China [8,9] and lower than study reported in in-hospital mortality in USA [11][12][13], Brazil [14], Spain [15][16][17], France [18,19] and Italy [20]. This prevalance is also lower than pooled meta prevalence of in-hospital mortality in patients with COVID-19 in the world [21].…”

Section: Discussionmentioning

confidence: 66%

“…The large cohort study in China ((9.6%)[8], 3.98% [9]), USA (8.2% [10], 18.58% [11], 45.11% [12], 22.77% [13]), Brazil (26.82% [14], Spain (21.3% [15], 20.90%[16], 21.41% [17]), France (16.87% [18], 27.72% [19]), Italy (28% [20]) reported various prevalence of in-hospital death due to COVID-19. Abate et al in a meta analysis study showed that the pooled prevalence of inhospital mortality in patients with coronavirus disease was 15% (95% CI: 13 to 17) [21]. in-hospital death is one of the qualitative indexes, which can be used to assess the resilience of a health system in Crisis situations.…”

Section: Contextmentioning

confidence: 99%

See 1 more Smart Citation

In-Hospital Death Due to COVID-19 Disease in Iranian Patients: A Systematic Review and Meta-Analysis Study

Ghanei

Saadat

Najimi-Varzaneh

et al. 2021

Preprint

View full text Add to dashboard Cite

Context: The prevalence of in-hospital death due to COVID-19 hospital is one of the qualitative indexes, which can be used to assess the quality of care, as well as the mortality patterns in COVID-19 pandemic.Objectives: Therefore, this systematic and meta-analysis study has been done with the aim of estimating overall prevalence in-hospital death due to COVID-19 disease in iranian patients Evidence Acquisition: Articles were identified through international searching databases including PubMed, Scopus, Elsevier, Google Scholar, and Web of Science and Iranian scientific information database (SID), Health.barakatkns, IranDoc, Civilica and MagIran. We reviewed systematically all studies reporting the prevalence of in-hospital death due to COVID-19 disease. In this study meta-analysis method with random effect model has been used to estimate the pooled prevalence. Results: 118 records were identified by the electronic search, of which 43 studies were identified as relevant papers that were meta-analyzed for the pooled in-hospital death due to COVID-19 prevalence. Overall, prevalence of death were 12.16% (95% CI: 10.72%-13.61%). The highest and lowest death prevalence has been reported in Northern Provinces (Gilan, 27.27% (95% CI: 8.66%-45.88%) and Mazandaran, 21.27% (95% CI: 18.14%-24.40%)) and Turkish-speaking provinces (Azerbaijan, East, 3.29% (95% CI: 2.11%-4.47%) and Zanjan, 3.42% (95% CI: 1.82%-5.02%)) respectively. Conclusions: Considering the death rate obtained in this study and its comparison with other countries, it can be said that the performance of the Iranian medical system in COVID-19 pandemic is acceptable.

show abstract

Section: Discussionmentioning

confidence: 66%

Section: Contextmentioning

confidence: 99%

In-Hospital Death Due to COVID-19 Disease in Iranian Patients: A Systematic Review and Meta-Analysis Study

Ghanei

Saadat

Najimi-Varzaneh

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…The highest COVID-19 case fatality rate is among the population with cardiovascular diseases and diabetes (Abate, Checkol & Mantefardo, 2021). Therefore, the Cardiovasc death rate (CARD) and diabetes prevalence (DIABET) values as at the beginning of 2020 were used as factors affecting the effectiveness of the fight against the pandemic (Hasell et al, 2020).…”

Section: Research Sample and The Results Processing Methodsmentioning

confidence: 99%

“…But as evidenced by the results of a study (Windsor et al, 2020), instead of a positive influence on the effectiveness of the fight against the virus, a pattern was revealed that more developed countries were more affected by the pandemic than less developed ones. H5: the people power characteristics of the population determine the effectiveness of the fight against a pandemic: average age, average life expectancy, and health status (Abate, Checkol & Mantefardo, 2021;Polidori et al, 2021).…”

Section: Introductionmentioning

confidence: 99%

Political elite behavior effectiveness in combating the COVID-19 pandemic: A case study of Vietnam

Trần¹

2021

JEECAR

View full text Add to dashboard Cite

The article aims to develop an empirical approach to identifying the key factors in the political elite behavior effectiveness in combating the COVID-19 pandemic propagation exemplified by Vietnam. Using regression analysis and the Chow test, we identified key behavioral factors that affect the effectiveness of the fight against the COVID-19 pandemic in terms of mortality rates and the state of the economy. The study sample was formed by data from 67 countries worldwide for 2020. The results suggest that the Rule of Law significantly influences the state of the economy in a pandemic. The COVID-19 mortality rate is affected by the Global Health Security Index, gender, and cultural factors. Based on the constructed linear multivariate regression models, we calculated the contribution of significant factors to the effectiveness of combating the pandemic in Vietnam, their stimulating and de-stimulating effects compared to the average values of these indicators for the sample countries.

show abstract

“…По данным других исследований полиморбидность также являлась предиктором неблагоприятного течения заболевания. По данным метаанализа Abate SM, et al, смертность среди госпитализированных пациентов с COVID-19 была в 2 раза выше у пациентов с какими-либо сопутствующими заболеваниями по сравнению с теми, у которых не было сопутствующих заболеваний, ОР =2,20 (95% ДИ 1,75-2,77) [15]. По данным регистра Cho SI, et al, индекс коморбидности Чарлсона (ИКЧ) с поправкой на возраст коррелировал со смертностью пациентов, и порог ИКЧ >3,5 давал наилучшую точку отсечения для прогнозирования смертности [40].…”

Section: клиническая и исследовательская медицинаunclassified

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19

Arutyunov¹,

Tarlovskaya²,

Arutyunov³

et al. 2021

Russ J Cardiol

View full text Add to dashboard Cite

The international AKTIV register presents a detailed description of out- and inpatients with COVID-19 in the Eurasian region. It was found that hospitalized patients had more comorbidities. In addition, these patients were older and there were more men than among outpatients. Among the traditional risk factors, obesity and hypertension had a significant negative effect on prognosis, which was more significant for patients 60 years of age and older. Among comorbidities, CVDs had the maximum negative effect on prognosis, and this effect was more significant for patients 60 years of age and older. Among other comorbidities, type 2 and 1 diabetes, chronic kidney disease, chronic obstructive pulmonary disease, cancer and anemia had a negative impact on the prognosis. This effect was also more significant (with the exception of type 1 diabetes) for patients 60 years and older. The death risk in patients with COVID-19 depended on the severity and type of multimorbidity. Clusters of diseases typical for deceased patients were identified and their impact on prognosis was determined. The most unfavorable was a cluster of 4 diseases, including hypertension, coronary artery disease, heart failure, and diabetes mellitus. The data obtained should be taken into account when planning measures for prevention (vaccination priority groups), treatment and rehabilitation of COVID-19 survivors.

show abstract

Global prevalence and determinants of mortality among patients with COVID-19: A systematic review and meta-analysis

Cited by 48 publications

References 65 publications

In-Hospital Death Due to COVID-19 Disease in Iranian Patients: A Systematic Review and Meta-Analysis Study

In-Hospital Death Due to COVID-19 Disease in Iranian Patients: A Systematic Review and Meta-Analysis Study

Political elite behavior effectiveness in combating the COVID-19 pandemic: A case study of Vietnam

International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19

Contact Info

Product

Resources

About